NL
CVS icon

NWAM LLC’s CVS Health CVS Stock Holding History

NWAM LLC’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$364K Buy
3,521
+420
+14% +$37.5K 0.02% 512
2026
Q1 		$223K Buy
+3,101
New +$239K 0.01% 577
2024
Q4 		– Sell
-3,655
Closed -$230K – 603
2024
Q3 		$230K Buy
+3,655
New +$213K 0.01% 558
2024
Q2 		– Sell
-4,810
Closed -$274K – 225
2024
Q1 		$274K Sell
4,810
-382
-7% -$29.2K 0.02% 452
2023
Q4 		$410K Sell
5,192
-101
-2% -$7.19K 0.03% 373
2023
Q3 		$370K Sell
5,293
-935
-15% -$66.3K 0.04% 351
2023
Q2 		$431K Sell
6,228
-1,072
-15% -$76.3K 0.04% 353
2023
Q1 		$542K Buy
7,300
+67
+0.9% +$5.62K 0.06% 261
2022
Q4 		$674K Buy
7,233
+685
+10% +$66.1K 0.06% 261
2022
Q3 		$624K Sell
6,548
-973
-13% -$96.3K 0.06% 268
2022
Q2 		$696K Buy
7,521
+496
+7% +$48.4K 0.06% 254
2022
Q1 		$711K Buy
7,025
+1,534
+28% +$161K 0.05% 270
2021
Q4 		$566K Sell
5,491
-576
-9% -$53.2K 0.04% 307
2021
Q3 		$515K Buy
6,067
+99
+2% +$8.29K 0.05% 316
2021
Q2 		$498K Sell
5,968
-178
-3% -$14.6K 0.05% 311
2021
Q1 		$462K Sell
6,146
-501
-8% -$36.5K 0.05% 314
2020
Q4 		$454K Buy
+6,647
New +$432K 0.05% 282
2020
Q1 		– Sell
-2,748
Closed -$204K – 374
2019
Q4 		$204K Buy
+2,748
New +$193K 0.04% 380
2018
Q1 		– Sell
-2,996
Closed -$217K – 345
2017
Q4 		$217K Sell
2,996
-1,143
-28% -$83.1K 0.06% 284
2017
Q3 		$337K Buy
4,139
+55
+1% +$4.35K 0.09% 220
2017
Q2 		$329K Buy
+4,084
New +$322K 0.06% 208

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

NWAM LLC's CVS Position: Q2 2026 in Review

NWAM LLC increased its CVS Health (CVS) stake by 14% in Q2 2026, buying an estimated $37.5K and bringing the position to 3,521 shares worth $364K. The position accounts for 0.02% of the portfolio, ranked #512.

NWAM LLC first reported a position in CVS in Q2 2017 and has held it in 21 quarters since. The position peaked at $711K in Q1 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • NWAM LLC held 3,521 shares of CVS Health worth $364K as of Q2 2026.
  • NWAM LLC bought 420 CVS Health shares in Q2 2026, an estimated $37.5K.
  • CVS Health made up 0.02% of NWAM LLC's portfolio in Q2 2026, its #512 holding.
  • NWAM LLC first reported a position in CVS Health in Q2 2017 and has held it in 21 quarters since.
  • NWAM LLC's CVS Health position peaked at $711K in Q1 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.